See the DrugPatentWatch profile for equetro
What is US Patent 6,977,253 (Equetro)?
US Patent 6,977,253 is a U.S. patent associated with the drug Equetro (brand name for carbamazepine; Equetro is a specific formulation). The patent is listed in DrugPatentWatch’s patent database for Equetro, which tracks patents and exclusivity relevant to the product’s legal timeline.1
What does this patent cover?
DrugPatentWatch’s listing ties US 6,977,253 to the Equetro product, but the page you’d typically use to research the details (claims, what exactly is patented—such as formulation, method of use, or composition aspects) is on the patent-tracking record itself.1
When does patent protection for Equetro end (and how do you check it)?
The most practical way to determine the time window for exclusivity is to use the DrugPatentWatch Equetro page, which compiles the active and relevant patents for the product and shows their key dates (including expiration timing as reflected in that database).1
Who is likely challenging this patent, and are there generic/biosimilar issues?
For many branded small-molecule products like Equetro, generic entry can depend on whether challengers can design around patented claims or wait out expiration. DrugPatentWatch is commonly used to identify which patents are listed for the brand and therefore may become obstacles for generic applicants as they seek approval.1
Where can I read the official patent record?
DrugPatentWatch links out from its Equetro patent listing to the patent information it tracks, which you can then use to cross-check details against the official USPTO record.1
Source (patent tracking)